Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

142
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
142
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

329
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
329
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

100
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
100
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

122
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
122
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

202
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
202
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

138
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
138

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Lower LDL-c/ApoB ratio is associated with adverse cardiovascular outcomes and advanced peripheral artery disease.

VASA. Zeitschrift fur Gefasskrankheiten·2026
Same author

Downhill-walking exercise training in a patient with symptomatic peripheral artery disease: A case report.

Vascular medicine (London, England)·2026
Same author

Peripheral artery disease: time to recognize the systemic burden and reorganize care.

European journal of preventive cardiology·2026
Same author

[The Role of Nailfold Capillaroscopy in Raynaud's Phenomenon and Autoimmune Diseases].

Revue medicale suisse·2026
Same author

Assessing preferred walking speed in patients with symptomatic chronic peripheral artery disease: Comparison of the 4-versus 10-meter walk test.

Vascular medicine (London, England)·2026
Same author

Structured exercise training and rehabilitation in patients with acute venous thromboembolism: a systematic review of randomized controlled trials.

European journal of preventive cardiology·2026

Related Experiment Video

Updated: Nov 10, 2025

Author Spotlight: Advancing Cardiovascular Imaging - Introducing the Spatially Weighted Calcium Score for Early Disease Detection
06:57

Author Spotlight: Advancing Cardiovascular Imaging - Introducing the Spatially Weighted Calcium Score for Early Disease Detection

Published on: September 22, 2023

1.2K

The atherosclerosis burden score.

Angeliki Koulouri1, Roger Darioli2, Salah Dine Qanadli3

  • 1Angiology, University Hospital CHUV, Lausanne, Switzerland.

VASA. Zeitschrift Fur Gefasskrankheiten
|April 1, 2021
PubMed
Summary
This summary is machine-generated.

The Atherosclerosis Burden Score (ABS) effectively predicts coronary artery disease (CAD) in asymptomatic individuals. It performs comparably to the coronary artery calcium (CAC) score in intermediate-risk patients and surpasses other non-radiation methods.

Keywords:
Framingham risk scorecardiovascular disease predictionsubclinical atherosclerosis imaging

More Related Videos

Quantification of Atherosclerosis in Mice
06:59

Quantification of Atherosclerosis in Mice

Published on: June 12, 2019

39.2K
Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
13:07

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression

Published on: January 15, 2022

4.2K

Related Experiment Videos

Last Updated: Nov 10, 2025

Author Spotlight: Advancing Cardiovascular Imaging - Introducing the Spatially Weighted Calcium Score for Early Disease Detection
06:57

Author Spotlight: Advancing Cardiovascular Imaging - Introducing the Spatially Weighted Calcium Score for Early Disease Detection

Published on: September 22, 2023

1.2K
Quantification of Atherosclerosis in Mice
06:59

Quantification of Atherosclerosis in Mice

Published on: June 12, 2019

39.2K
Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
13:07

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression

Published on: January 15, 2022

4.2K

Area of Science:

  • Cardiology
  • Vascular Imaging
  • Preventive Medicine

Background:

  • Coronary artery disease (CAD) poses a significant health risk.
  • Accurate risk stratification in asymptomatic individuals is crucial for primary prevention.
  • Non-invasive imaging modalities are essential for assessing cardiovascular disease (CVD) risk.

Purpose of the Study:

  • To evaluate the Atherosclerosis Burden Score (ABS) for predicting CAD in asymptomatic patients.
  • To compare ABS predictive accuracy against coronary artery calcium (CAC) score, carotid intima-media thickness (C-IMT), and ankle brachial index (ABI).

Main Methods:

  • Prospective study of 198 asymptomatic patients.
  • Assessment of traditional cardiovascular risk factors, ABS, CAC score, C-IMT, and ABI.
  • Coronary CT-angiography (CCTA) used to define CAD (coronary stenosis ≥30%).

Main Results:

  • CAC score showed the highest predictive value (ROC-AUC 0.81) overall.
  • ABS demonstrated a comparable predictive value to CAC score (ROC-AUC 0.70 vs 0.76) in intermediate-risk patients.
  • ABS outperformed C-IMT and ABI in predicting CAD across patient groups.

Conclusions:

  • ABS is a valuable non-invasive tool for predicting CAD in asymptomatic individuals.
  • ABS shows similar performance to CAC score in intermediate-risk patients.
  • ABS offers a safe, radiation-free alternative for identifying high-risk patients needing intensive CVD prevention therapy.